comparemela.com

Latest Breaking News On - How to training videos - Page 1 : comparemela.com

Bispecific CD3 Molecules in Oncology, 2024 Analytical

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) The

Dublin
Ireland
Business-development-licensing
Clinical-trial-development
Biomarker-companion-diagnostic-development
Analytical-tool
Conference-coverage
Companion-diagnostic-development
Therapy-choices
Business-development
How-to-training-videos

2023 Analytical Tool on Targeting the CD47-SIRPA Axis in Oncology - Intense Global Interest and a Growing List of Stakeholders Operating in this Field

/PRNewswire/ The "Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. Targeting the.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Analytical-tool
Conference-coverage
Companion-diagnostic-development
Therapy-choices

RNA Therapies in Oncology Analysis 2022: Coverage of 127 Companies Plus Partners Developing 274 RNA Therapy Drugs with 182 in Active Development Across 122 Different Targets

/PRNewswire/ The "RNA Therapies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. RNA Therapies in Oncology:.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Analytical-tool
Business-development
How-to-training-videos
Analytical-tools

DNA Damage Response (DDR) Drugs in Oncology Analysis 2022: Coverage of 399 Companies Plus Partners Developing 835 DDR Drugs with 412 in Active Development Across 226 Different Targets

/PRNewswire/ The "DNA Damage Response (DDR) Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. DNA Damage.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Analytical-tool
Business-development
How-to-training-videos
Analytical-tools

Epigenetic Therapies in Oncology Analytical Tool 2022: Coverage of 111 Companies Plus Partners Developing 221 Epigentic Drugs with 148 in Active Development Across 62 Different Targets

/PRNewswire/ The "Epigenetic Therapies in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com s offering. In cancer, many aspects of.

Dublin
Ireland
Laura-wood
E-st-office-hours-call
Office-hours-call
Clinical-trial-development
Biomarker-companion-diagnostic-development
Business-development-licensing
Analytical-tool
Epigenetic-therapies
Business-development
How-to-training-videos

vimarsana © 2020. All Rights Reserved.